[Morbidity and treatment of penile cancer (based on data from the Moscow Municipal Oncology Dispensary)]
Related Experiment Video
Updated: Aug 14, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Abstract:
Penis carcinoma morbidity in the city of Moscow in 1973-1979 was 0.5 per 100,000 of male population, most of the patients being older than 60 years. On primary application, stage I of the disease was identified in 17.5%; stage II -- 42.9%; stage III -- 34.9% and stage IV in 4.7% of patients. Therefore, advanced tumors were found in 39.6% of patients. Combined treatment was given to 31.6%, radiation alone -- 37.5%, surgery -- 21.3% and symptomatic therapy -- 7.4% of cases. Three patients refused to take therapy.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis

